drugset
drugset / Trial / NCT03354533

Study of ORL-1F (L-fucose) in Patients With Leukocyte Adhesion Deficiency Type II

NCT03354533 ↗

Phase 1/2 Completed 4 enrolled Orpha Labs
NaSingle-groupOpen-labelTreatment

Summary

Study of ORL-1F in Patients With Leukocyte Adhesion Deficiency Type II

Timeline

Start
2012-01-01
Primary completion
2018-11-01
Completion
2018-11-01

Drugs

EvaluationDrugModalityDoseRoute
Subject L-fucose Unknown — Oral

Indications

leukocyte adhesion deficiency type II